EISENBERG GLENN A — SEC insider filings
SEC reporting owner CIK 1222831. 47 insider filings on record with FilingPulse; latest filed 2026-10-13.
Transaction summary — filings shown
Covers all 47 filings on record, filed 2020-08-11 to 2026-10-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 15 legs across 5 filings — 118,315 shares, $27,044,368 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 114.
- Largest priced transaction: sale of 19,338 shares @ $254.26 ($4,916,861) in LABCORP HOLDINGS INC., filed 2022-08-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | Executive Vice President | 31 | — | 15 legs · 118,315 sh · $27,044,368 | 94 |
| Solventum Corp (SOLV) | Director | 6 | — | — | 10 |
| MIDDLEBY Corp (MIDD) | Director | 2 | — | — | 2 |
| MiniMed Group, Inc. (MMED) | Director | 2 | — | — | 2 |
| Perspecta Inc. (PRSP) | Director | 2 | — | — | 2 |
| US Ecology, Inc. (ECOL) | Director | 2 | — | — | 2 |
| Fortrea Holdings Inc. (FTRE) | Executive Vice President, Director | 1 | — | — | 1 |
| Lumexa Imaging Holdings, Inc. (LMRI) | Director | 1 | — | — | 1 |
Insider filings — EISENBERG GLENN A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-13 | 4 | MiniMed Group, Inc. (MMED) | Grant/award (A): 11,795 @ $0 | EDGAR |
| 2026-08-28 | 4 | MIDDLEBY Corp (MIDD) | Conversion (C): 349 | EDGAR |
| 2026-06-12 | 4 | Lumexa Imaging Holdings, Inc. (LMRI) | Grant/award (A): 19,358 @ $0 | EDGAR |
| 2026-05-18 | 4 | Solventum Corp (SOLV) | Grant/award (A): 3,300 (derivative) @ $0 | EDGAR |
| 2026-05-01 | 4 | Solventum Corp (SOLV) | Option exercise (M): 3,403 @ $0 · Option exercise (M): 3,403 (derivative) @ $0 | EDGAR |
| 2026-03-30 | 4 | Solventum Corp (SOLV) | Option exercise (M): 1,980 @ $0 · Option exercise (M): 1,980 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | MiniMed Group, Inc. (MMED) | Grant/award (A): 13,889 @ $0 | EDGAR |
| 2026-03-06 | 4 | MIDDLEBY Corp (MIDD) | Grant/award (A): 1,161 | EDGAR |
| 2025-05-15 | 4 | Solventum Corp (SOLV) | Option exercise (M): 3,564 @ $0 · Option exercise (M): 3,564 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | Solventum Corp (SOLV) | Grant/award (A): 3,403 (derivative) @ $0 | EDGAR |
| 2025-03-31 | 4 | LABCORP HOLDINGS INC. (LH) | Grant/award (A): 8,305 @ $0 · Tax withholding (F): 3,630 @ $231.67 | EDGAR |
| 2025-02-13 | 4 | LABCORP HOLDINGS INC. (LH) | Option exercise (M): 807 · Tax withholding (F): 213 @ $245.14 · Option exercise (M): 807 (derivative) @ $0 | EDGAR |
| 2025-02-10 | 4 | LABCORP HOLDINGS INC. (LH) | Option exercise (M): 966 · Tax withholding (F): 255 @ $247.74 · Option exercise (M): 885 · Tax withholding (F): 234 @ $246.27 · Option exercise (M): 966 (derivative) @ $0 · Option exercise (M): 885 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4 | LABCORP HOLDINGS INC. (LH) | Option exercise (M): 8,923 @ $209.25 · Option exercise (M): 2,788 @ $221.67 · Sale (S): 11,711 @ $240.43 · Option exercise (M): 8,923 (derivative) @ $0 · Option exercise (M): 2,788 (derivative) @ $0 | EDGAR |
| 2024-08-19 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 2,979 @ $222.65 · Sale (S): 2,950 @ $223.62 · Sale (S): 9,071 @ $224.55 | EDGAR |
| 2024-05-15 | 4 | Solventum Corp (SOLV) | Grant/award (A): 3,564 (derivative) @ $0 · Grant/award (A): 1,980 (derivative) @ $0 | EDGAR |
| 2024-05-02 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 10,229 · Tax withholding (F): 4,496 @ $201.37 · Option exercise (M): 10,229 (derivative) | EDGAR |
| 2024-04-17 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 10,229 · Tax withholding (F): 4,496 @ $203.32 · Option exercise (M): 10,229 (derivative) @ $0 | EDGAR |
| 2024-03-29 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 20,033 · Tax withholding (F): 8,805 @ $216.57 · Option exercise (M): 20,033 (derivative) | EDGAR |
| 2024-02-22 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 14,054 @ $163.63 · Sale (S): 18,379 @ $215.37 · Sale (S): 7,907 @ $215.68 · Sale (S): 6,665 @ $217.52 · Sale (S): 1,553 @ $217.98 · Option exercise (M): 14,054 (derivative) @ $0 | EDGAR |
| 2024-02-13 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 807 · Tax withholding (F): 215 @ $227.45 · Option exercise (M): 807 (derivative) @ $0 | EDGAR |
| 2024-02-08 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 885 · Tax withholding (F): 236 @ $223.71 · Grant/award (A): 2,900 (derivative) @ $0 · Grant/award (A): 9,000 (derivative) @ $0 · Option exercise (M): 885 (derivative) @ $0 | EDGAR |
| 2024-02-06 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 856 · Tax withholding (F): 228 @ $221.54 · Option exercise (M): 856 (derivative) @ $0 | EDGAR |
| 2023-07-05 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Grant/award (A): 20,193 (derivative) @ $0 | EDGAR |
| 2023-06-21 | 4 | Fortrea Holdings Inc. (FTRE) | Other (J): 42,176 @ $0 | EDGAR |
| 2023-04-03 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Grant/award (A): 11,715 @ $0 · Tax withholding (F): 5,179 @ $224.70 | EDGAR |
| 2023-02-14 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 723 · Tax withholding (F): 195 @ $248.13 · Option exercise (M): 723 (derivative) @ $0 | EDGAR |
| 2023-02-09 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Grant/award (A): 2,380 (derivative) @ $0 · Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2023-02-07 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 970 · Tax withholding (F): 261 @ $244.50 · Option exercise (M): 970 (derivative) @ $0 | EDGAR |
| 2023-02-06 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 767 · Tax withholding (F): 206 @ $254.99 · Option exercise (M): 767 (derivative) @ $0 | EDGAR |
| 2022-11-03 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 12,032 · Tax withholding (F): 5,348 @ $222.56 · Grant/award (A): 9,170 (derivative) @ $0 · Grant/award (A): 9,170 (derivative) @ $0 · Option exercise (M): 12,032 (derivative) @ $0 | EDGAR |
| 2022-09-28 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Sale (S): 5,627 @ $209.29 · Sale (S): 4,844 @ $210.21 · Sale (S): 11,699 @ $211.13 · Sale (S): 2,830 @ $211.86 | EDGAR |
| 2022-08-05 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 11,400 @ $130.60 · Option exercise (M): 9,100 @ $168.49 · Option exercise (M): 11,600 @ $146.59 · Sale (S): 11,262 @ $253.26 · Sale (S): 19,338 @ $254.26 · Sale (S): 1,500 @ $254.88 · +3 more | EDGAR |
| 2022-05-03 | 4 | US Ecology, Inc. (ECOL) | Disposition to issuer (D): 9,000 @ $48 | EDGAR |
| 2022-03-29 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Grant/award (A): 14,144 @ $0 · Tax withholding (F): 6,286 @ $276.42 | EDGAR |
| 2022-02-15 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 940 · Tax withholding (F): 277 @ $272.68 · Grant/award (A): 2,170 (derivative) @ $0 · Grant/award (A): 7,700 (derivative) @ $0 · Option exercise (M): 940 (derivative) @ $0 | EDGAR |
| 2022-02-08 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 970 · Tax withholding (F): 286 @ $277.48 · Option exercise (M): 970 (derivative) @ $0 | EDGAR |
| 2022-02-04 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 766 · Tax withholding (F): 236 @ $273.18 · Option exercise (M): 766 (derivative) @ $0 | EDGAR |
| 2021-11-03 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 9,024 · Tax withholding (F): 4,034 @ $288.78 · Option exercise (M): 9,024 (derivative) @ $0 | EDGAR |
| 2021-05-28 | 4 | US Ecology, Inc. (ECOL) | Grant/award (A): 2,900 @ $0 | EDGAR |
| 2021-05-06 | 4 | Perspecta Inc. (PRSP) | Disposition to issuer (D): 14,400 | EDGAR |
| 2021-03-30 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Grant/award (A): 8,042 @ $0 · Tax withholding (F): 3,595 @ $251.58 | EDGAR |
| 2021-02-17 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 780 · Tax withholding (F): 232 @ $238.26 · Option exercise (M): 940 · Tax withholding (F): 280 @ $238.26 · Option exercise (M): 780 (derivative) @ $0 · Option exercise (M): 940 (derivative) @ $0 | EDGAR |
| 2021-02-08 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 970 · Tax withholding (F): 306 @ $223.78 · Option exercise (M): 970 (derivative) @ $0 | EDGAR |
| 2021-02-04 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Grant/award (A): 2,300 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2020-11-04 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 9,024 · Tax withholding (F): 4,034 @ $207.23 · Option exercise (M): 9,024 (derivative) @ $0 | EDGAR |
| 2020-08-11 | 4 | Perspecta Inc. (PRSP) | Grant/award (A): 6,800 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1222831 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs